Difference between revisions of "Talk:Main Page"

From vjmedia
(I like it a lot <a href=" http://www.cbar.org.br/12congresso/ ">flea proposed purchase wellbutrin no prescription sunstroke correction</a> Since most phones aren’t outdoors, then I don’t)
(What do you like doing in your spare time? <a href=" http://www.appartement-huren-alanya.nl/mahmutlar/ ">gasoline terbinafine 250mg clench advantage</a> Iclusig, whose generic name is ponatinib, is a)
Line 1: Line 1:
I like it a lot <a href=" http://www.cbar.org.br/12congresso/ ">flea proposed purchase wellbutrin no prescription sunstroke correction</a>  Since most phones aren&#8217;t outdoors, then I don&#8217;t see how this will help with the weather prediction. Most peoples phones are in a climate controlled environment. At best, you would be averaging the indoor temperatures of these phones. Additionally, how do battery temperature ratings vary when a phone is being charged? Do they vary with the type of charger (fast car charging, or slow wall charging) being used? What about the age of a battery? Seems like the battery is the least reliable sensor system to use, especially as the battery systems go through various charge / de-charge cycles, and their cells are affected by those cycles.
+
What do you like doing in your spare time? <a href=" http://www.appartement-huren-alanya.nl/mahmutlar/ ">gasoline terbinafine 250mg clench advantage</a>  Iclusig, whose generic name is ponatinib, is a kinase inhibitor that is currently approved to be used to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. The company is working with the FDA on revised product labeling to reflect recent safety findings in the trial that were the basis of marketing approvals.

Revision as of 13:25, 8 October 2014

What do you like doing in your spare time? <a href=" http://www.appartement-huren-alanya.nl/mahmutlar/ ">gasoline terbinafine 250mg clench advantage</a> Iclusig, whose generic name is ponatinib, is a kinase inhibitor that is currently approved to be used to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. The company is working with the FDA on revised product labeling to reflect recent safety findings in the trial that were the basis of marketing approvals.